Michele Cavo
0000-0003-4514-3227
590 papers found
Refreshing results…
Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia
VarianThinker: a classification method to confidently approach the mutation heterogeneity in Multiple Myeloma
Spontaneous remission of follicular lymphoma
Facing lenalidomide-refractory myeloma
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies
Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs
Understanding mortality in multiple myeloma: Findings of a European retrospective chart review
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis
90 Y-Ibritumomab Tiuxetan in Patients With Extra-Nodal Marginal Zone B-Cell Lymphoma of Mucosa Associated Lymphoid Tissue (Malt Lymphoma) - The Zeno Study
BRAF V600E-positive monomorphic epitheliotropic intestinal T-cell lymphoma complicating the course of hairy cell leukemia
Development and internal validation of a model for predicting 60-day risk of invasive mould disease in patients with haematological malignancies
International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors
Expert Panel Consensus Statement for Proper Evaluation of First Relapse in Multiple Myeloma
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
Liver Stiffness Measurement Allows Early Diagnosis of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Adult Patients Who Undergo Hematopoietic Stem Cell Transplantation: Results from a Monocentric Prospective Study
Impact of 2016‐WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib
Prevention, monitoring and treatment of cardiovascular adverse events in myeloma patients receiving carfilzomib A consensus paper by the European Myeloma Network and the Italian Society of Arterial Hypertension
Missing publications? Search for publications with a matching author name.